← Back to Analyst Consensus 
CAI Buy
Caris Life Sciences, Inc.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 3 reiterations from 3 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Oct 14, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Oct 13, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Sep 9, 2026 | UBS | initiate | — → Neutral | — | 54% |
| Aug 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Aug 6, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Aug 5, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jul 2, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 8, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 8, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| May 8, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Apr 13, 2026 | Jefferies | initiate | — → Buy | — | 52% |
| Apr 10, 2026 | Piper Sandler | initiate | — → Neutral | — | 54% |
| Apr 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Mar 13, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Feb 27, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $34 | 58% |
| Feb 27, 2026 | Baird | maintain | Outperform → Outperform | $28 | 55% |
| Feb 27, 2026 | BTIG | maintain | Buy → Buy | $38 | 52% |
| Feb 17, 2026 | Baird | initiate | — → Outperform | $26 | 55% |
| Dec 22, 2025 | Canaccord Genuity | maintain | Hold → Hold | $30 | 48% |
| Dec 2, 2025 | Canaccord Genuity | initiate | — → Hold | $28 | 48% |
| Aug 13, 2025 | Guggenheim | maintain | Buy → Buy | $36 | 52% |
| Aug 13, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $40 | 58% |
| Aug 13, 2025 | Citigroup | maintain | Buy → Buy | $42 | 54% |
| Jul 15, 2025 | Evercore ISI Group | initiate | — → Outperform | $33 | 58% |
| Jul 14, 2025 | TD Cowen | initiate | — → Buy | $32 | 54% |
| Jul 14, 2025 | Guggenheim | initiate | — → Buy | $32 | 52% |
| Jul 14, 2025 | Wolfe Research | initiate | — → Outperform | $32 | 54% |
| Jul 14, 2025 | Citigroup | initiate | — → Buy | $34 | 54% |
| Jul 14, 2025 | JP Morgan | initiate | — → Overweight | $31 | 55% |
Price Target Trend
Apr 21, 2026 Latest: $32.08 Oct 24, 2026
EPS Estimates
0q $0.02
Lo: $-0.01 Hi: $0.07
10 analysts ▲3
+1q $0.11
Lo: $0.05 Hi: $0.19
10 analysts ▲6
+1y $0.37
Lo: $0.05 Hi: $0.52
11 analysts ▲2
0y $0.14
Lo: $0.04 Hi: $0.26
11 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days